Resection of Renal Cell Cancer Metastases: Where Do We Stand in 2008?

Lam, 2005, Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy, J Urol, 173, 1853, 10.1097/01.ju.0000165693.68449.c3 Ljungberg, 2004, Prognostic factors in renal cell carcinoma, Scand J Surg, 93, 118, 10.1177/145749690409300206 Montie, 1977, The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma, J Urol, 117, 272, 10.1016/S0022-5347(17)58429-3 Marcus, 1993, Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy, J Urol, 150, 463, 10.1016/S0022-5347(17)35514-3 Wagner, 1999, Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place, J Urol, 162, 43, 10.1097/00005392-199907000-00011 Flanigan, 2001, Nephrectomy followed by interferon α-2b compared with interferon α-2b alone for metastatic renal-cell cancer, N Engl J Med, 345, 1655, 10.1056/NEJMoa003013 Mickisch, 2001, Radical nephrectomy plus interferon-α-based immunotherapy compared with interferon α alone in metastatic renal-cell carcinoma: a randomized trial, Lancet, 358, 966, 10.1016/S0140-6736(01)06103-7 Flanigan, 2004, Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis, J Urol, 171, 1071, 10.1097/01.ju.0000110610.61545.ae www.clinicaltrials.gov. Kavolius, 1998, Resection of metastatic renal cell carcinoma, J Clin Oncol, 16, 2261, 10.1200/JCO.1998.16.6.2261 van der Poel, 1999, Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis, Eur Urol, 35, 197, 10.1159/000019849 Blom, 1999, Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. EORTC Genitourinary Group, Eur Urol, 36, 570, 10.1159/000020050 Pantuck, 2003, Renal cell carcinoma with retroperitoneal lymph nodes: role of lymphatic dissection, J Urol, 169, 2076, 10.1097/01.ju.0000066130.27119.1c Canfield, 2006, Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome, J Urol, 175, 864, 10.1016/S0022-5347(05)00334-4 Karakiewicz, 2007, Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival, Eur Urol, 51, 1616, 10.1016/j.eururo.2006.12.015 Fourquier, 1997, Lung metastases of renal cell carcinoma: results of surgical resection, Eur J Cardiothor Surg, 11, 17, 10.1016/S1010-7940(96)01013-5 Pilz, 2002, Long-term results after pulmonary resection of renal cell carcinoma metastases, Ann Thorac Surg, 73, 1082, 10.1016/S0003-4975(01)03602-5 Pfannschmidt, 2002, Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma, Ann Thorac Surg, 74, 1653, 10.1016/S0003-4975(02)03803-1 Hofmann, 2005, Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma, Eur Urol, 48, 77, 10.1016/j.eururo.2005.03.004 Sudish, 2005, Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma?, Ann Thorac Surg, 79, 996, 10.1016/j.athoracsur.2004.08.034 Assouad, 2007, Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors, Ann Thor Surg, 84, 1114, 10.1016/j.athoracsur.2007.04.118 Coppin C, Porzsolt F, Awa A, et al. Immunotherapy for advanced renal cell cancer. The Cochrane Database of Systematic Reviews 2004. Issue 3. Umeda, 1986, Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials, Cancer, 58, 1231, 10.1002/1097-0142(19860915)58:6<1231::AID-CNCR2820580610>3.0.CO;2-# Jacobsohn, 2006, Adjuvant therapy for renal cell carcinoma, Semin Oncol, 33, 576, 10.1053/j.seminoncol.2006.06.005 Jung, 2003, Treatment of osseous metastases in patients with renal cell carcinoma, Clin Orthop Rel Res, 409, 223, 10.1097/01.blo.0000059580.08469.3e Fuchs, 2005, Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment, Clin Orthop Relat Res, 431, 187, 10.1097/01.blo.0000149820.65137.b4 Lin, 2007, Patient survival after surgery for osseous metastases from renal cell carcinoma, J Bone Joint Surg Am, 89, 1794, 10.2106/JBJS.F.00603 Wronski, 1996, Surgical resection of brain metastases from renal cell carcinoma in 50 patients, Urology, 47, 187, 10.1016/S0090-4295(99)80413-0 Sheehan, 2003, Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control, J Neurosurg, 98, 342, 10.3171/jns.2003.98.2.0342 Yen, 2006, Gamma knife surgery for metastatic brain stem tumors, J Neurosurg, 105, 213, 10.3171/jns.2006.105.2.213 Shuto, 2006, Gamma knife surgery for metastatic brain tumors from renal cell carcinoma, J Neurosurg, 105, 555, 10.3171/jns.2006.105.4.555 Unnithan, 2007, Safety of VEGF-targeted tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma (mRCC) and central nervous system (CNS) metastases, Proc Am Soc Clin Oncol, 25, 766 Thelen, 2007, Liver resection for metastases from renal cell carcinoma, World J Surg, 31, 802, 10.1007/s00268-007-0685-9 Bruno, 2006, Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival, Br J Urol Int, 97, 933, 10.1111/j.1464-410X.2006.06076.x Leibovich, 2005, A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials, J Urol, 174, 1759, 10.1097/01.ju.0000177487.64651.3a